Kidney Transplantation Clinical Trial
Official title:
Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China
The primary objective of this study is to evaluate graft survival and recipient survival
among kidney transplant recipients in China, and also to analyze possible factors related to
patient and graft survival.
The secondary objective is to evaluate several secondary outcomes among kidney transplant
recipients, such as average creatinine value, acute rejection episodes, NODM, incidence of
BKV infection etc. At the same time analyze possible impact factors related to these
secondary outcomes.
Renal transplantation is the choice for patients with end-stage renal disease. In the past
two decades, progress in surgical procedure, medical care, and immunosuppression have
significantly improved the short-term results of organ transplantation. Nevertheless, grafts
continue to fail over time, these improvements in immunosuppression and reduced incidence of
acute rejection episodes have had only minimal effects on chronic allograft dysfunction and
late graft loss. Long-term patient's death and graft failure are the main limitations for a
better performance of renal transplant programs.
Multiple factors have been shown to affect the outcome of renal transplantation. These
include demographic characteristics such as race and ethnicity, pretransplantation dialysis
course, the timing of the transplantation,and the patients' co morbidities. Patient response
to the transplantation procedure (e.g., delayed graft function, acute rejection, and acute
tubular necrosis) is strongly associated with the long-term prognosis. In the last decade,
with the increase of immunosuppressive agents in our therapeutic arsenal, several attempts
have been made to improve graft performance. However, the majority of trials aiming to avoid
calcineurin inhibitor (CNI)-related nephrotoxicity only reported short-term data. Also, and
because of the lack of assessment of the role of the different ethiopathogenic factors that
lead to graft damage, just avoiding CNI-related nephrotoxicity may be an oversimplification
of the problem in the prevention of graft attrition.
There are many studies which have evaluated the long-term outcomes of graft and patient
survival and have analyzed multiple relative factors. Unfortunately, such data in Chinese
population are lacking. Meanwhile, the situation in China is somewhat different with others,
such as race, the dosage of immunosuppressant and so on. A better characterization of the
weight of immune and non-immune factors responsible for graft damage may help us to improve
the outcomes in transplant recipients. Studies derived from well-designed and well-performed
patient registries can provide a real world view of clinical practice, patient outcomes,
safety, and comparative effectiveness and cost effectiveness. The goal of this project is to
analyze retrospective data collected by disease registry, then to evaluate the graft and
recipient outcomes of kidney transplants and relative impact factors.
;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04910867 -
APOL1 Genetic Testing Program for Living Donors
|
N/A | |
Completed |
NCT02723591 -
To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients
|
Phase 4 | |
Completed |
NCT05945511 -
Silent Gallbladder Stone in Kidney Transplantation Recipients: Should it be Treated?
|
||
Completed |
NCT02234349 -
Bile Acids and Incretins in Pancreas Kidney Transplant Patients
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 | |
Recruiting |
NCT05917795 -
Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
|
N/A | |
Not yet recruiting |
NCT05934383 -
Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hypertension
|
N/A | |
Withdrawn |
NCT04936971 -
Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response
|
Phase 4 | |
Not yet recruiting |
NCT04540640 -
Oxygenated Machine Preservation in Kidney Transplantation
|
N/A | |
Not yet recruiting |
NCT03090828 -
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
|
N/A | |
Recruiting |
NCT02908139 -
Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients
|
N/A | |
Completed |
NCT02560558 -
Bela 8 Week Dosing
|
Phase 4 | |
Terminated |
NCT02417870 -
Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation
|
Phase 1/Phase 2 | |
Recruiting |
NCT02154815 -
Pre-emptive Kidney Transplantation Quality of Life
|
N/A | |
Completed |
NCT02235571 -
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
|
N/A | |
Enrolling by invitation |
NCT01905514 -
ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients
|
N/A | |
Completed |
NCT02147210 -
Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1
|
N/A | |
Recruiting |
NCT01699360 -
The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients
|
Phase 4 | |
Completed |
NCT01655563 -
Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation
|
Phase 2 | |
Terminated |
NCT01436305 -
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
|
Phase 2 |